NCT04671030View on ClinicalTrials.gov

Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

June 22, 2018

Study Completion Date

June 3, 2021

Conditions
Spinal Cord InjuriesConstipationNeurogenic Bowel
Interventions
DRUG

Neostigmine and Glycopyrrolate

Intravenous followed by transdermal administration of the two drug combination.

DEVICE

Iontophoresis

Application of direct current to skin using an FDA-approved device

Trial Locations (1)

10468

James J Peters VA Medical Center, The Bronx

All Listed Sponsors
lead

James J. Peters Veterans Affairs Medical Center

FED

NCT04671030 - Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI | Biotech Hunter | Biotech Hunter